TradingView
MarketMoversReport
29 мар 2022 г., 16:02
Antares Pharma Announces FDA Approval Of TLANDO
Длинная
NASDAQ:ATRS
Описание
⋅
29 мар 2022 г., 16:02
ATRS: Antares Pharma, Inc.
2022-03-29 07:00:00
Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy
Beyond Technical Analysis
Ещё